Critical Drug-Drug Interactions for Use in Electronic Health Records Systems With Computerized Physician Order Entry: Review of Leading Approaches

被引:44
|
作者
Classen, David C. [1 ,2 ]
Phansalkar, Shobha [3 ,4 ,5 ]
Bates, David W. [3 ,4 ,5 ]
机构
[1] Univ Utah, Sch Med, Div Infect Dis, Salt Lake City, UT USA
[2] CSC, Salt Lake City, UT USA
[3] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA USA
[5] Partners HealthCare Syst, Wellesley, MA USA
关键词
drug-drug interactions; clinical decision support; electronic health records; patient safety;
D O I
10.1097/PTS.0b013e31821d6f6e
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Medications represent the most common intervention in health care, despite their benefits; they also lead to an estimated 1.5 million adverse drug events and tens of thousands of hospital admissions each year. Although some are not preventable given what is known today, many types are, and one key cause which is preventable is drug-drug interactions (DDIs). Most electronic health record systems include programs that can check and prevent these types of interactions as a routine part of medication ordering. Studies suggest that these systems as implemented often do not effectively screen for these DDIs. A major reason for this deficiency is the lack of any national standard for the critical DDIs that should be routinely operationlized in these complex systems. We review the leading critical DDI lists from multiple sources including several leading health systems, a leading commercial content provider, the Leapfrog CPOE Testing Standard, and the new Office of the National Coordinator (ONC) DDI List. Implementation of strong DDI checking is one of the important steps in terms of realizing the benefits of electronic prescribing with respect to safety. Hopefully, the ONC list will make it easier for organizations to ensure they are including the most important interactions, and the Leapfrog List may help these organizations develop an operational DDI list that can be practically implemented. In addition, this review has identified 7 common DDIs that can be the starting point for all organizations in this area of medication safety.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 50 条
  • [41] Review of Statistical Methodologies for Detecting Drug-Drug Interactions Using Spontaneous Reporting Systems
    Noguchi, Yoshihiro
    Tachi, Tomoya
    Teramachi, Hitomi
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [42] Approaches to Recording Drug Allergies in Electronic Health Records: Qualitative Study
    Fernando, Bernard
    Morrison, Zoe
    Kalra, Dipak
    Cresswell, Kathrin
    Sheikh, Aziz
    PLOS ONE, 2014, 9 (04):
  • [43] Detection of Drug–Drug Interactions Inducing Acute Kidney Injury by Electronic Health Records Mining
    Yannick Girardeau
    Claire Trivin
    Pierre Durieux
    Christine Le Beller
    Lillo-Le Louet Agnes
    Antoine Neuraz
    Patrice Degoulet
    Paul Avillach
    Drug Safety, 2015, 38 : 799 - 809
  • [44] Impact of alerts in the computerized physician order entry on drug dosage adequacy for chronic kidney disease patients
    Desmedt, S.
    Henrard, S.
    Wouters, D.
    Spinewine, A.
    Dalleur, O.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2012, 34 (01) : 215 - 216
  • [45] Effects of Shared Electronic Health Record Systems on Drug-Drug Interaction and Duplication Warning Detection
    Rinner, Christoph
    Grossmann, Wilfried
    Sauter, Simone Katja
    Wolzt, Michael
    Gall, Walter
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [46] DDIWAS: High-throughput electronic health record-based screening of drug-drug interactions
    Wu, Patrick
    Nelson, Scott D.
    Zhao, Juan
    Stone, Cosby A., Jr.
    Feng, QiPing
    Chen, Qingxia
    Larson, Eric A.
    Li, Bingshan
    Cox, Nancy J.
    Stein, C. Michael
    Phillips, Elizabeth J.
    Roden, Dan M.
    Denny, Joshua C.
    Wei, Wei-Qi
    JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2021, 28 (07) : 1421 - 1430
  • [47] Outcomes of Computerized Physician Order Entry in an Electronic Health Record After Implementation in an Outpatient Oncology Setting
    Harshberger, Cara A.
    Harper, Abigail J.
    Carro, George W.
    Spath, Wayne E.
    Hui, Wendy C.
    Lawton, Jessica M.
    Brockstein, Bruce E.
    JOURNAL OF ONCOLOGY PRACTICE, 2011, 7 (04) : 233 - +
  • [48] Analysis of variations in the display of drug names in computerized prescriber-order-entry systems
    Quist, Arbor J. L.
    Hickman, Thu-Trang T.
    Amato, Mary G.
    Volk, Lynn A.
    Salazar, Alejandra
    Robertson, Alexandra
    Wright, Adam
    Bates, David W.
    Phansalkar, Shobha
    Lambert, Bruce L.
    Schiff, Gordon D.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2017, 74 (07) : 499 - 509
  • [49] National standards for computerized prescriber order entry and clinical decision support: The case of drug interactions
    Mulherin, David P.
    Zimmerman, Christopher R.
    Chaffee, Bruce W.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (01) : 59 - 64
  • [50] High-priority and low-priority drug-drug interactions in different international electronic health record systems: A comparative study
    Cornu, Pieter
    Phansalkar, Shobha
    Seger, Diane L.
    Cho, Insook
    Pontefract, Sarah
    Robertson, Alexandra
    Bates, David W.
    Slight, Sarah P.
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2018, 111 : 165 - 171